Tag Archives: action

P2P Participation, Part 2

I have new information on participation in the Pathways to Prevention ME/CFS Workshop: The Office of Disease Prevention confirmed via telephone that the public will be able to participate in discussion at the P2P Workshop, in person and online. ODP … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , | 14 Comments

Why You Should P2P

My concerns about the NIH’s Pathways to Prevention Workshop on ME/CFS are legion, and I’ve been quite vocal about them. But today I am asking you to participate in the P2P Workshop on December 9-10, 2014. Registration for attending in … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 35 Comments

La La La, I Can’t Hear You

On May 28th, Mary Dimmock and I sent NIH Director Dr. Francis Collins a 38 page packet outlining our concerns that the P2P Workshop will not advance the ME/CFS research field, and may even set it back. We finally got … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 19 Comments

ME/CFS Mortality

Does ME/CFS kill? This critical question has received very little attention from researchers, but there is a way for you to help change that. The first paper on causes of death in ME/CFS was published in 2006 by Dr. Leonard … Continue reading

Posted in Research | Tagged , , , , , , , , , , , | 23 Comments

Guest Post: CFSAC Comments of Charmian Proskauer

Charmian delivered these comments at today’s CFS Advisory Committee meeting. She has kindly given me permission to publish them here in their entirety. My name is Charmian Proskauer, and I currently serve as President of the Massachusetts CFIDS/ME & FM … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , , | 1 Comment

Comment for the June 2014 CFS Advisory Committee

These are the comments I delivered by telephone to the CFS Advisory Committee today. For the record, the operator told me that they were instructed to cut people off precisely at 3 minutes. Mary Dimmock and I wrote to Dr. … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 2 Comments

Guest Post: CFSAC Comments of Joe Landson

Joe Landson delivered these comments at the CFS Advisory Committee meeting today. He has kindly given me permission to post them in their entirety here. Testimony of Joseph D. Landson June 2014 Chronic Fatigue Syndrome Advisory Committee First, credit where … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , | 6 Comments

P2P Spin

Listen carefully to the agency updates at the June 16th CFS Advisory Committee meeting. Updates on the P2P Workshop and systematic evidence review may sound reasonable, but I suspect that hidden within will be some spin-doctoring to deflect our concerns … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , , | 14 Comments

A Different CFSAC

It’s that time again: meaning it is time for another CFS Advisory Committee meeting. Due to the make up day in March, the meetings have fallen very close together. Presumably this spring meeting puts the calendar back on track (but … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , | Comments Off on A Different CFSAC

Tell Dr. Collins to Stop P2P

As I explain in this previous post, Mary Dimmock and I have sent a letter to Dr. Francis Collins requesting that he cancel the P2P Workshop and reexamine the best way to collaborate with the ME/CFS research and clinical community. … Continue reading

Posted in Advocacy | Tagged , , , , , , , , , , | 20 Comments